Saskia Räuber

1.2k total citations
25 papers, 275 citations indexed

About

Saskia Räuber is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Saskia Räuber has authored 25 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 7 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in Saskia Räuber's work include Multiple Sclerosis Research Studies (7 papers), Autoimmune Neurological Disorders and Treatments (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Saskia Räuber is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Autoimmune Neurological Disorders and Treatments (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Saskia Räuber collaborates with scholars based in Germany, Austria and United States. Saskia Räuber's co-authors include Heinz Wiendl, Sven G. Meuth, Tobias Ruck, Gerd Meyer zu Hörste, Michael Heming, Anne K. Mausberg, Thorsten Brenner, Xiaolin Li, Michael Fleischer and Anna‐Lena Börsch and has published in prestigious journals such as Immunity, Annals of Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Saskia Räuber

23 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saskia Räuber Germany 8 129 63 60 51 49 25 275
Anna‐Lena Börsch Germany 5 95 0.7× 57 0.9× 130 2.2× 51 1.0× 34 0.7× 7 284
R. Gold Germany 9 80 0.6× 57 0.9× 55 0.9× 27 0.5× 113 2.3× 22 353
Ruturaj Masvekar United States 13 44 0.3× 119 1.9× 83 1.4× 26 0.5× 80 1.6× 18 353
Asher Khan United States 6 161 1.2× 175 2.8× 51 0.8× 94 1.8× 11 0.2× 12 427
Marina Mané-Damas Netherlands 11 151 1.2× 57 0.9× 19 0.3× 30 0.6× 15 0.3× 22 261
Kathryn B. Holroyd United States 10 172 1.3× 60 1.0× 27 0.5× 73 1.4× 108 2.2× 31 322
Nobuaki Yoshikura Japan 12 259 2.0× 130 2.1× 73 1.2× 28 0.5× 44 0.9× 47 410
Alessandro F. Fois Australia 8 142 1.1× 63 1.0× 33 0.6× 22 0.4× 33 0.7× 20 326
Fiona Tea Australia 8 124 1.0× 58 0.9× 42 0.7× 10 0.2× 80 1.6× 12 242
Grace Gombolay United States 11 178 1.4× 25 0.4× 16 0.3× 45 0.9× 116 2.4× 41 319

Countries citing papers authored by Saskia Räuber

Since Specialization
Citations

This map shows the geographic impact of Saskia Räuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia Räuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia Räuber more than expected).

Fields of papers citing papers by Saskia Räuber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saskia Räuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia Räuber. The network helps show where Saskia Räuber may publish in the future.

Co-authorship network of co-authors of Saskia Räuber

This figure shows the co-authorship network connecting the top 25 collaborators of Saskia Räuber. A scholar is included among the top collaborators of Saskia Räuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saskia Räuber. Saskia Räuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winter, Pia, S. Wolff, Alice Willison, et al.. (2025). Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(8). 802–806. 1 indexed citations
2.
Roll, Wolfgang, Jan Bauer, Andre Dik, et al.. (2024). [18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis. Journal of Neurology. 271(6). 3653–3659. 2 indexed citations
3.
Schroeter, Christina B., Niklas Huntemann, Saskia Räuber, et al.. (2024). Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice. Cells. 13(6). 508–508. 4 indexed citations
4.
Meuth, Sven G., S. Wolff, Alice Willison, et al.. (2024). Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab. Annals of Neurology. 97(3). 583–595. 4 indexed citations
5.
6.
Masanneck, Lars, Saskia Räuber, Christina B. Schroeter, et al.. (2023). Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany. Digital Health. 9. 589796701–589796701. 8 indexed citations
7.
Schroeter, Christina B., Corinna Preuße, Marc Pawlitzki, et al.. (2023). Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis. Acta Neuropathologica. 146(5). 725–745. 19 indexed citations
8.
Nelke, Christopher, Christina B. Schroeter, Frauke Stascheit, et al.. (2023). Eculizumab treatment alters the proteometabolome beyond the inhibition of complement. JCI Insight. 8(13). 5 indexed citations
9.
Pfeuffer, Steffen, Leoni Rolfes, Jens Ingwersen, et al.. (2023). Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab. Neurology Neuroimmunology & Neuroinflammation. 10(3). 4 indexed citations
10.
Langenbruch, Lisa, Johanna Maria Helena Rau, Tobias Brix, et al.. (2022). Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort. Archives of Clinical Neuropsychology. 37(4). 738–752. 7 indexed citations
11.
Räuber, Saskia, Marc Pawlitzki, Melanie Korsen, et al.. (2022). A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab. Multiple Sclerosis and Related Disorders. 59. 103670–103670. 5 indexed citations
12.
Kamp, Daniel, et al.. (2022). Social interaction, psychotic disorders and inflammation: A triangle of interest. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 122. 110697–110697. 5 indexed citations
13.
Masanneck, Lars, Leoni Rolfes, Alice Willison, et al.. (2022). Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies. Multiple Sclerosis and Related Disorders. 63. 103927–103927. 17 indexed citations
14.
Nelke, Christopher, Marc Pawlitzki, Christina B. Schroeter, et al.. (2022). High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies. Cells. 11(20). 3330–3330. 3 indexed citations
15.
Epping, Lisa, Christina B. Schroeter, Christopher Nelke, et al.. (2022). Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells. Cellular and Molecular Life Sciences. 79(9). 479–479. 17 indexed citations
16.
Räuber, Saskia, Michael Heming, Jonathan Repple, et al.. (2021). Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses. Molecular Psychiatry. 26(12). 7661–7670. 18 indexed citations
17.
Nelke, Christopher, Andreas Schulte‐Mecklenbeck, Marc Pawlitzki, et al.. (2021). The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome. Journal of Clinical Immunology. 41(6). 1229–1240. 5 indexed citations
18.
Pawlitzki, Marc, Christopher Nelke, Leoni Rolfes, et al.. (2021). NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection. Cells. 10(10). 2551–2551. 11 indexed citations
19.
Dik, Andre, Guido Widman, Andreas Schulte‐Mecklenbeck, et al.. (2021). Impact of T cells on neurodegeneration in anti‐GAD65 limbic encephalitis. Annals of Clinical and Translational Neurology. 8(12). 2289–2301. 16 indexed citations
20.
Heming, Michael, Xiaolin Li, Saskia Räuber, et al.. (2020). Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity. 54(1). 164–175.e6. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna‐Lena Börsch Breakdown of academic impact, for papers by R. Gold Breakdown of academic impact, for papers by Ruturaj Masvekar Breakdown of academic impact, for papers by Asher Khan Breakdown of academic impact, for papers by Marina Mané-Damas Breakdown of academic impact, for papers by Kathryn B. Holroyd Breakdown of academic impact, for papers by Nobuaki Yoshikura Breakdown of academic impact, for papers by Alessandro F. Fois Breakdown of academic impact, for papers by Fiona Tea Breakdown of academic impact, for papers by Grace Gombolay
Rankless by CCL
2026